Silver Book Fact

Medicare beneficiaries with vision loss incur significantly higher costs than individuals with normal vision. Approximately 90% of the higher annual costs are non-eye related medical costs– $2,193 for those with moderate loss, $3,301 for those with severe loss, and $4,443 for those who are blind. Extrapolating to the entire Medicare population, blindness and vision loss are associated with $2.14 billion in non-eye related costs (in 2003 dollars).

Javitt, Jonathan C., Zhiyuan Zhou, and Richard J. Wilke. Association Between Vision Loss and Higher Medical Care Costs in Medicare Beneficiaries: Costs are greater for those with progressive vision loss. Ophthalmology. 2007; 114(2): 238-45. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17270673&dopt=AbstractPlus

Reference

Title
Association Between Vision Loss and Higher Medical Care Costs in Medicare Beneficiaries: Costs are greater for those with progressive vision loss
Publication
Ophthalmology
Publication Date
2007
Authors
Javitt, Jonathan C., Zhiyuan Zhou, and Richard J. Wilke
Volume & Issue
Volume 114, Issue 2
Pages
238-45
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Age-related eye diseases are the primary causes of vision impairment and blindness in the U.S.  
  • Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in people over the age of 65.  
  • Annual Total Burden to the U.S. Economy of AMD, Cararact, Diabetic Retinopathy, Glaucoma, Refractive Errors, Visual Impairment and Blindness  
  • The average cost in 2004 per age-related macular degeneration (AMD) patient age 40 and older using medications and vitamins was $110.  
  • More than 7.6 million Americans age 40 and older have diabetic retinopathy—7,685,237.